Clinical trial readout dates for Arcutis Biotherapeutics Inc., compiled from
ClinicalTrials.gov, alongside the SEC filings where results are announced.
The next expected readout is April 2028.
Arcutis Biotherapeutics Inc. reported $259M in cash, cash equivalents and marketable securities at Sep 30, 2026 (10-Q filed 2026-11-04). It reported net income of $9M for that quarter.
Recent SEC filings
8-KResults of Operations — earnings, may carry pipeline updates